Results 121 to 130 of about 14,613 (227)

Incidence of All-Cause, Cardiovascular, and Atrial Fibrillation-Related Hospitalizations

JACC: Advances
Background: Atrial fibrillation (AF) is associated with an increased risk of hospital admission, but few data on reasons for hospitalization and on the role of anti-arrhythmic drugs are available.
Danilo Menichelli, MD, Pasquale Pignatelli, MD, PhD, Tommaso Brogi, MD, Arianna Pannunzio, MD, Francesco Violi, MD, Gregory Y.H. Lip, MD, Daniele Pastori, MD, Tiziana Di Stefano, Elio Sabbatini, Patrizia Iannucci, Alberto Befani, Ilaria Maria Palumbo, Emanuele Valeriani   +12 more
doaj   +1 more source

Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment

, 1988
As a class IC antiarrhythmic drug, flecainide can produce marked widening of the QRS complex. This effect is use dependent,1 indicating that widening of the QRS complex becomes more prominent during faster heart rates.
Lie, KI, VANGELDER, IC, van Gelder, IC, Crijns, HJ   +3 more
core   +1 more source

Results of a Survey “Ethacizine evaluation for acute and chronic treatment of atrial fibrillation in real practice: Ukrainian national survey (ETERNITY)”

Сучасні медичні технології
The aim of the study: based on a survey of physicians, the study aims to identify the real clinical practices regarding the use of class IC antiarrhythmic drugs in Ukraine, particularly ethacizine, for restoring sinus rhythm in paroxysmal and persistent ...
N. M. Sydorova, M. Yu. Kolesnyk
doaj   +1 more source

The Effect of Psychotropic Agents on Sick Sinus Syndrome: A Case Report. [PDF]

Cureus
Fadel L, Malik A, Pemminati S.
europepmc   +1 more source

Flecainide Induced Myoclonus and Severe Asthenia Necessitating Intensive Care Unit Management and Intubation: A Case Report

Flecainide is class Ic antiarrhythmic drug with a narrow therapeutic range. Adverse drug reactions during flecainide therapy are predominately cardiac in nature. Severe neurological adverse drug reactions have rarely been described.
Joseph Blunck, Andrew Schlachter, Justin Shewmaker   +2 more
core   +1 more source

Device Interrogation Unmasking Flecainide-Induced Wide Complex Tachycardia. [PDF]

JACC Case Rep
Segar MW, Lambeth KD, Hastedt AJ, Molina-Razavi JE.   +3 more
europepmc   +1 more source

Fulminant flecainide intoxication in an adolescent: cardiogenic shock requiring VA-ECMO support. [PDF]

BMJ Case Rep
Kovacevic M, Bešenji I, Jarakovic M, Radonjic J, Stefanovic M, Crnomarkovic B, Keca S, Dimic S, Bjelica S, Srdanovic I.   +9 more
europepmc   +1 more source

Temporary Rhythm Control with Flecainide in Atrial Fibrillation-Related Conversion Pauses Prior to Catheter Ablation: A Case of Successful Pharmacological Bridging. [PDF]

Int Med Case Rep J
Skakun O, Varunkiv O, Symchych A, Symchych K, Vandzhura I, Vandzhura Y, Denina R, Zvonar P, Rudnyk V.   +8 more
europepmc   +1 more source

Solvates of Flecainide Base

, 2008
Flekainīda bāzes solvāti. Ļubova Jansone, darba vadītājs Dr.chem., asoc. prof. Andris Actiņš. Bakalaura darbs 33 lappuses, 19 attēli, 5 tabulas, 15 literatūras avoti. Latviešu valodā.
Jansone, Ļubova
core  

Short-Coupled Purkinje Ventricular Fibrillation Triggers Successfully Suppressed With Flecainide. [PDF]

JACC Case Rep
Ahmad E, Abdalaziz MH, Tawney A, Mehta N, Kutinsky IB.   +4 more
europepmc   +1 more source